SCHEMBL7014377

SCHEMBL7014377

CCc1cc2cc(OC)ccn2c1C(=O)C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM2B Q8NHM5 10/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
PDE4B Q07343 1/20 0.38
PDE4D Q08499 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
MAPT P10636 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012314 0.76 ADORA2A (0.37) MEN1KMT2AMTNR1AMTNR1B
SCHEMBL7013787 0.74 CYP1A2 (0.47) ALDH1A1PDE4DMEN1KMT2AMAPT
SCHEMBL7011107 0.67 SGMS2 (0.43) KDM2BALDH1A1MEN1KMT2A
SCHEMBL1039910 0.65 MEN1 (0.61) KDM2BALDH1A1PDE4BPDE4DMEN1
SCHEMBL1036177 0.65 MEN1 (0.61) KDM2BALDH1A1PDE4BPDE4DMEN1
SCHEMBL18360283 0.65 KDM2B (0.62) KDM2BALDH1A1MEN1KMT2AMTNR1A
SCHEMBL4115692 0.65 KDM2B (0.47) KDM2BKDM4EALDH1A1MEN1KMT2A
SCHEMBL4113759 0.65 MAPT (0.61) KDM2BKDM4EALDH1A1PDE4BPDE4D
SCHEMBL14435190 0.64 MEN1 (0.45) KDM2BKDM4EALDH1A1MEN1KMT2A
SCHEMBL4611341 0.64 NPC1 (0.75) KDM2BALDH1A1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0772596-A4 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 1999-01-13 EP disclosed
EP-0772596-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1997-05-14 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed